Prehospital
Literature Index
Neurology

Telemedicine Can Replace the Neurologist on a Mobile Stroke Unit.

Tzu-Ching Wu, Stephanie A Parker, Amanda Jagolino, Jose-Miguel Yamal, Ritvij Bowry, Abraham Thomas, Amy Yu, James C Grotta

Stroke · 2017-01-12 · Randomised trial

Read at publisher · PubMed

Abstract

BACKGROUND AND PURPOSE: The BEST-MSU study (Benefits of Stroke Treatment Delivered Using a Mobile Stroke Unit) is a comparative effectiveness trial in patients randomized to mobile stroke unit or standard management. A substudy tested interrater agreement for tissue-type plasminogen activator eligibility between a telemedicine vascular neurologist and onboard vascular neurologist. METHODS: On scene, both the telemedicine vascular neurologist and onboard vascular neurologist independently evaluated the patient, documenting their tissue-type plasminogen activator treatment decision, National Institutes of Health Stroke Scale score, and computed tomographic interpretation. Agreement was determined using Cohen κ statistic. Telemedicine-related technical failures that impeded remote assessment were recorded. RESULTS: Simultaneous and independent telemedicine vascular neurologist and onboard vascular neurologist assessment was attempted in 174 patients. In 4 patients (2%), the telemedicine vascular neurologist could not make a decision because of technical problems. The telemedicine vascular neurologist agreed with the onboard vascular neurologist on 88% of evaluations (κ=0.73). CONCLUSIONS: Remote telemedicine vascular neurologist assessment is reliable and accurate, supporting either telemedicine vascular neurologist or onboard vascular neurologist assessment on our mobile stroke unit. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT02190500.

Abstract © the authors or publisher, via PubMed. Reuse and removal

Tags

Antithrombotics & thrombolytics · Mobile stroke unit · Prehospital physicians · Telemedicine · Thrombolytics

Related articles